feed,title,long_url,short_url
Benzinga,Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer,https://benzinga.com/general/biotech/21/08/22349342/sanofi-regenerons-libtayochemo-treatment-improves-overall-survival-first-line-lung-cancer,https://j.mp/3yquv7e
